ATE485519T1 - Verfahren zum nachweis von hepatitis-c-virus - Google Patents

Verfahren zum nachweis von hepatitis-c-virus

Info

Publication number
ATE485519T1
ATE485519T1 AT04793357T AT04793357T ATE485519T1 AT E485519 T1 ATE485519 T1 AT E485519T1 AT 04793357 T AT04793357 T AT 04793357T AT 04793357 T AT04793357 T AT 04793357T AT E485519 T1 ATE485519 T1 AT E485519T1
Authority
AT
Austria
Prior art keywords
hcv
virus
treating
agent
samples
Prior art date
Application number
AT04793357T
Other languages
English (en)
Inventor
Katsumi Aoyagi
Kumiko Iida
Naoko Matsubara
Original Assignee
Advanced Life Science Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34510313&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE485519(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Advanced Life Science Inst Inc filed Critical Advanced Life Science Inst Inc
Application granted granted Critical
Publication of ATE485519T1 publication Critical patent/ATE485519T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/116—Togaviridae (F); Matonaviridae (F); Flaviviridae (F)
    • C07K16/118—Hepatitis C virus; GB virus C [GBV-C]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT04793357T 2003-10-28 2004-10-28 Verfahren zum nachweis von hepatitis-c-virus ATE485519T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003367783 2003-10-28
PCT/JP2004/016377 WO2005040815A1 (ja) 2003-10-28 2004-10-28 Ｃ型肝炎ウイルスの検出方法

Publications (1)

Publication Number Publication Date
ATE485519T1 true ATE485519T1 (de) 2010-11-15

Family

ID=34510313

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04793357T ATE485519T1 (de) 2003-10-28 2004-10-28 Verfahren zum nachweis von hepatitis-c-virus

Country Status (10)

Country Link
US (1) US8546075B2 (de)
EP (1) EP1691198B1 (de)
JP (1) JP4744298B2 (de)
KR (2) KR20070108284A (de)
CN (2) CN1871518B (de)
AT (1) ATE485519T1 (de)
CA (1) CA2544185C (de)
DE (1) DE602004029707D1 (de)
TW (1) TWI344002B (de)
WO (1) WO2005040815A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005111620A1 (ja) * 2004-05-19 2005-11-24 Advanced Life Science Institute, Inc. Ｂ型肝炎ウィルスの検出方法
JP2009018990A (ja) * 2005-10-25 2009-01-29 Univ Kurume Ｃ型肝炎ウイルス由来ペプチド
US20090280474A1 (en) * 2008-05-08 2009-11-12 Abbott Laboratories Method for detecting a virus
JP5618570B2 (ja) * 2010-02-26 2014-11-05 シスメックス株式会社 Ｃ型肝炎ウイルスの免疫測定方法及びそれに用いる試薬キット
CN102081018A (zh) * 2009-11-30 2011-06-01 希森美康株式会社 样品的预处理方法及hcv的免疫测定方法
JP5351724B2 (ja) * 2009-11-30 2013-11-27 シスメックス株式会社 Ｃ型肝炎ウイルスのコア蛋白の検出方法及び検出用試薬キット
CA2810770A1 (en) * 2010-09-07 2012-03-15 Smart Biotech Ltd. Methods and kits for the detection of an infection in subjects with low specific antibody levels
JP6641841B2 (ja) * 2015-09-29 2020-02-05 富士レビオ株式会社 ヒトパルボウイルスｂ１９抗原の測定方法
JP2019523863A (ja) * 2016-05-31 2019-08-29 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ウイルス抗原の血清学的検出方法
ES2796479T3 (es) * 2016-05-31 2020-11-27 Hoffmann La Roche Procedimiento de pretratamiento para la detección rápida del antígeno central del VHC
EP3929584B1 (de) * 2016-09-06 2024-08-14 Fujirebio Inc. Verfahren zur messung von thyreoglobulin
EP3511713B1 (de) * 2016-09-06 2021-10-27 Fujirebio Inc. Tumormarkermessverfahren und -messreagenz
TW201812300A (zh) * 2016-09-13 2018-04-01 日商富士麗比歐股份有限公司 心肌肌鈣蛋白之測定方法及測定試藥
JP6801381B2 (ja) * 2016-11-07 2020-12-16 東ソー株式会社 凍結乾燥状態の検体前処理試薬
WO2018181263A1 (ja) * 2017-03-27 2018-10-04 日本ハム株式会社 体液による抗原抗体反応阻害を防止する物質
US11564392B2 (en) 2017-09-18 2023-01-31 Bayer Healthcare Llc Methods of inactivation of viruses using n-methlyglucamide and its derivatives
ES2991988T3 (es) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica
WO2019219154A1 (en) * 2018-05-14 2019-11-21 Abd El Motaleb Mohammed Abd Allah Taha Separation of antigens and hcv by diluted acids
CN110794149B (zh) * 2019-11-28 2023-05-12 南京迪安医学检验所有限公司 一种丙型肝炎病毒抗体的检测试剂
JP7843250B2 (ja) * 2021-01-18 2026-04-09 富士レビオ株式会社 可溶性ｇｐｃ３のイムノアッセイにおける可溶性ｇｐｃ３含有検体の処理方法
JP7691845B2 (ja) * 2021-05-11 2025-06-12 富士レビオ株式会社 ＳＡＲＳ－ＣｏＶ－２の免疫学的検出方法および試薬
CN113552358B (zh) * 2021-09-03 2024-08-30 郑州安图生物工程股份有限公司 一种hcv病毒裂解剂及其制备方法、hcv病毒检测试剂盒

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016687B (en) * 1978-03-20 1982-09-08 Abbott Lab Sugar coated reagents for solid phase immunoassay
US4609630A (en) * 1983-03-23 1986-09-02 Yanovsky Jorge F Method for improving the specificity of immunoassays
US4703001A (en) 1985-10-23 1987-10-27 Synbiotics, Corporation Immunoassay for the detection of serum analytes using pH dependent chastropic acids
DE3718140A1 (de) 1987-05-29 1988-12-08 Boehringer Mannheim Gmbh Heterogener immunoassay
CH673407A5 (de) 1987-06-24 1990-03-15 Sulzer Ag
JP2548756B2 (ja) * 1987-12-08 1996-10-30 三菱重工業株式会社 窒素酸化物の除去用触媒
JP2800221B2 (ja) * 1988-03-09 1998-09-21 三菱瓦斯化学株式会社 イオウ含有芳香族ビニル化合物
US5151370A (en) 1990-10-11 1992-09-29 Synermed, Inc. Reagent and method for serum iron assay
FI952779L (fi) * 1992-12-07 1995-07-31 Akzo Nobel Nv HCV:n C33-alueen peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi
JP3217600B2 (ja) 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
JPH0862219A (ja) * 1994-08-19 1996-03-08 Dainabotsuto Kk 還元型抗原に対する抗体アッセイ試薬及びそれを使用した測定方法
US5616460A (en) * 1995-06-07 1997-04-01 Abbott Laboratories Buffer composition for reagents for immunoassay
JP3176570B2 (ja) * 1997-08-04 2001-06-18 株式会社先端生命科学研究所 Ｈｃｖの検出又は測定方法
ES2286852T3 (es) 1997-08-04 2007-12-01 Advanced Life Science Institute, Inc. Metodos para detectar o analizar virus.
JP3171827B2 (ja) * 1997-08-04 2001-06-04 株式会社先端生命科学研究所 ウイルスの検出又は測定方法
AU9498098A (en) 1997-09-22 1999-04-12 Chiron Corporation Buffers for stabilizing antigens
US6393260B1 (en) * 1998-04-17 2002-05-21 Nokia Mobile Phones Limited Method for attenuating spurious signals and receiver
DK1071955T4 (da) * 1998-04-17 2009-06-15 Innogenetics Nv Forbedrede immundiagnostiske assays, som anvender reduktionsmidler
CA2305192C (en) * 1998-07-30 2009-10-13 Advanced Life Science Institute, Inc. Method for assaying hepatitis c virus
FR2791138B1 (fr) 1999-03-19 2001-04-27 Abx Sa Reactif pour la determination des leucocytes et la mesure de l'hemoglobine dans un echantillon de sang
US20020037868A1 (en) * 1999-04-14 2002-03-28 Institut Pasteur Method for detecting hepatitis C
JP4298850B2 (ja) * 1999-06-24 2009-07-22 シスメックス株式会社 Ｃ型肝炎ウィルス（ｈｃｖ）検出方法
KR100340046B1 (ko) * 1999-11-01 2002-06-12 오길록 다중 대역 및 다중 모드용 주파수 변환 수신기
US20030186285A1 (en) * 2000-08-01 2003-10-02 Noriyuki Saito Method of pretreating sample
US7101683B2 (en) * 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies

Also Published As

Publication number Publication date
US8546075B2 (en) 2013-10-01
HK1094037A1 (en) 2007-03-16
JPWO2005040815A1 (ja) 2007-04-26
DE602004029707D1 (de) 2010-12-02
EP1691198A4 (de) 2008-03-05
KR100830723B1 (ko) 2008-05-20
US20080044807A1 (en) 2008-02-21
KR20060061400A (ko) 2006-06-07
WO2005040815A1 (ja) 2005-05-06
EP1691198B1 (de) 2010-10-20
CA2544185C (en) 2010-09-28
EP1691198A1 (de) 2006-08-16
JP4744298B2 (ja) 2011-08-10
KR20070108284A (ko) 2007-11-08
TWI344002B (en) 2011-06-21
CA2544185A1 (en) 2005-05-06
CN101892199A (zh) 2010-11-24
TW200526959A (en) 2005-08-16
CN1871518A (zh) 2006-11-29
CN1871518B (zh) 2010-08-25

Similar Documents

Publication Publication Date Title
ATE485519T1 (de) Verfahren zum nachweis von hepatitis-c-virus
EP1435974A4 (de) Verfahren und zusamemnsetzungen zur behandlung des hepatitis-c-virus mit 4'-modifizierten nucleosiden
DE50105898D1 (de) Verfahren zum Herstellen von Seitenfaltensäcken aus Kunststofffolie
ATE465742T1 (de) Tlr7-liganden zur behandlung von hepatitis c
ATA8612001A (de) Verfahren zum testen von software
DE50104569D1 (de) Verfahren zum behandeln von tabak
DE60216514D1 (de) Verfahren zur behandlung von dämpferkondensat
DE60110072D1 (de) Verfahren zur Verhütung von Verschmutzung und Korrosion durch Ammoniumchlorid und Ammoniumsulfat
DE60112926D1 (de) Formbares positionierungssystem mit öffnungen und verfahren zum ausrichten von teilen
ATE493659T1 (de) Verfahren zum nachweis von hepatitis-b-virus
DE60019554D1 (de) Verfahren zum formen von blasgeformten gegenständen
DK2161283T3 (da) SAMMENSÆTNINGER OMFATTENDE ANTISTOFFER MOD CD79b, SOM ER KONJUGERET TIL ET VÆKSTINHIBERENDE MIDDEL ELLER ET CYTOTOKSISK MIDDEL, OG FREMGANGSMÅDER TIL BEHANDLING AF TUMOR AF HÆMATOPOIETISK OPRINDELSE
DE69923278D1 (de) Verfahren zum herstellen von zusammenhängenden beuteln
ATE426815T1 (de) Verfahren zur verbesserung einer bindungseigenschaft eines molekuls
DE59905958D1 (de) Verfahren zur reinigung von triethanolamin
DE69908622D1 (de) Verfahren zur abschreckung gasförmiger acrylnitrilcyanid produktströme
DE60207938D1 (de) Verfahren zum Herstellen von wiederverschliessbaren Kunststoffbeuteln
WO2007001323A3 (en) Methods and compositions for inhibiting, destroying, and/or inactivating viruses
DE60213900D1 (de) Bolzen und diesen verwendendes Verfahren zum Spannen von Bauteilen
DE602005016895D1 (de) Verfahren zum Behandeln von Wäschestücken
DE602004029691D1 (de) Verfahren zur einführung eines gens in pflanzenmaterial
DE60201984D1 (de) Werkzeugstahl von hoher zähigkeit, verfahren zum herstellen von teilen aus diesem stahl und so hergestellte teile
ATE292557T1 (de) Verfahren zum herstellen von kunststoffbeuteln
DE602004015454D1 (de) Verfahren und vorrichtung zur kontinuierlichen radioaktiven markierung von proteinen im grossen massstab
DE60129933D1 (de) Verfahren zum screening

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties